Mizuho Securities USA’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
15,146
+3,165
+26% +$278K 0.02% 530
2026
Q1
$1.08M Sell
11,981
-2,449
-17% -$225K 0.03% 527
2025
Q4
$1.41M Buy
14,430
+2
+0% +$190 0.02% 513
2025
Q3
$1.53M Buy
14,428
+748
+5% +$74.1K 0.03% 494
2025
Q2
$1.25M Sell
13,680
-2,260
-14% -$219K 0.03% 506
2025
Q1
$1.8M Sell
15,940
-2,928
-16% -$313K 0.04% 414
2024
Q4
$1.99M Buy
18,868
+5,662
+43% +$608K 0.04% 414
2024
Q3
$1.43M Sell
13,206
-2,656
-17% -$290K 0.03% 421
2024
Q2
$1.72M Buy
+15,862
New +$1.87M 0.04% 399

Other funds holding ZBH

Mizuho Securities USA's ZBH Position: Q2 2026 in Review

Mizuho Securities USA increased its Zimmer Biomet (ZBH) stake by 26% in Q2 2026, buying an estimated $278K and bringing the position to 15,146 shares worth $1.3M. The position accounts for 0.02% of the portfolio, ranked #530.

Mizuho Securities USA first reported a position in ZBH in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.99M in Q4 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Mizuho Securities USA held 15,146 shares of Zimmer Biomet worth $1.3M as of Q2 2026.
  • Mizuho Securities USA bought 3,165 Zimmer Biomet shares in Q2 2026, an estimated $278K.
  • Zimmer Biomet made up 0.02% of Mizuho Securities USA's portfolio in Q2 2026, its #530 holding.
  • Mizuho Securities USA first reported a position in Zimmer Biomet in Q2 2024 and has held it in 9 quarters since.
  • Mizuho Securities USA's Zimmer Biomet position peaked at $1.99M in Q4 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.